Consensus Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 01:30:02 12/09/2024 am IST			5-day change	1st Jan Change
114.71 ^USD	-0.54%		-0.94%	+5.22%

11/09	Merck: positive results for HPV vaccine	CF
11/09	Merck's HPV Vaccine Meets Main Goal in Phase 3 Study in Japanese Males	MT

Evolution of the Average Target: Merck & Co., Inc.

Evolution of the Target Price: Merck & Co., Inc.

Changes in Analyst Recommendations: Merck & Co., Inc.

fc.IZmm3FWRX4IA9GLeVRE_bhSk_oK1tiK4oqdqwl88QtY.ftHek2KkHsdZjg7mD2dYFHbNmeGEx03elpQlkg5dK69N6M-rOqg70mG-Mw~92f8cb85f617cbbc832fef8890219d30

Analysts' recommendations: Merck & Co., Inc.

Citic Securities Initiates Merck & Co. at Buy With $136 Price Target	29/08	MT
Jefferies Adjusts Merck & Company Price Target to $147 From $150	15/08	MT
Deutsche Bank Adjusts Price Target on Merck to $145 From $140	08/08	MT
Berenberg Adjusts Price Target on Merck & Co. to $135 From $143, Maintains Buy Rating	08/08	MT
Daiwa Securities Adjusts Merck & Company Price Target to $130 From $150, Maintains Outperform Rating	06/08	MT
UBS Adjusts Merck & Co.'s Price Target to $142 From $148, Maintains Buy Rating	31/07	MT
Morgan Stanley Adjusts Price Target on Merck & Company to $130 From $134	31/07	MT
Goldman Sachs Adjusts Price Target on Merck & Company to $140 From $145, Maintains Buy Rating	31/07	MT
Guggenheim Adjusts Price Target on Merck & Company to $138 From $142, Maintains Buy Rating	31/07	MT
Wolfe Research Adjusts Price Target on Merck & Co. to $142 From $151, Maintains Outperform Rating	31/07	MT
Barclays Adjusts Price Target on Merck & Co. to $142 From $145, Maintains Overweight Rating	31/07	MT
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating	31/07	MT
BMO Capital Adjusts Price Target on Merck to $150 From $148	19/07	MT
TD Cowen Adjusts Price Target on Merck to $140 From $135	17/07	MT
Goldman Sachs Adjusts Price Target on Merck & Company to $145 From $144	16/07	MT
Morgan Stanley Adjusts Price Target on Merck to $134 From $132	11/07	MT
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating	05/06	MT
Analyst recommendations: Boeing, Dell, Merck, RyanAir...	27/05
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142	01/05	MT
Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	26/04	MT
Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	26/04	MT
Guggenheim Adjusts Price Target on Merck to $146 From $144	26/04	MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	26/04	MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135	26/04	MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140	26/04	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	MERCK & CO., INC.					+21.20%
	ELI LILLY AND COMPANY					+7.16%
	NOVO NORDISK A/S					+8.65%
	JOHNSON & JOHNSON					+3.55%
	ABBVIE INC.					+0.88%
	ROCHE HOLDING AG					+10.86%
	ASTRAZENECA PLC					+14.91%
	NOVARTIS AG					+1.49%
	AMGEN INC.					-1.60%
	PFIZER, INC.					+12.05%
	Average					+7.92%
	Weighted average by Cap.					+7.78%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

114.71USD

Average target price

139.03USD

Spread / Average Target

+21.20%

High Price Target

155.00USD

Spread / Highest target

+35.12%

Low Price Target

120.00USD

Spread / Lowest Target

+4.61%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HSBC
Redburn Atlantic
Wolfe Research
Morgan Stanley
Guggenheim
Deutsche Bank Securities
JPMorgan Chase
Wells Fargo Securities
Goldman Sachs
Leerink Partners
Truist Securities
Jefferies & Co.
Cantor Fitzgerald
BMO Capital
Zacks Investment Research
Berenberg Bank
Societe Generale
UBS
Barclays
BofA Securities
TD Cowen
Atlantic Equities
Citigroup
Credit Suisse
SVB Securities LLC
Daiwa Securities
Cowen
SVB Leerink
Argus
RBC Capital Markets
RBC	Randall Stanicky
JPMORGAN